Oral Anticoagulation for Atrial Fibrillation in Octogenarians Across the Renal Function Spectrum

ConclusionDOACs seem to be safe and effective in octogenarians with chronic kidney disease at stage  ≥ G3b. As compared with VKA administration, the use of DOACs was associated with lower mortality rates among AF octogenarians with renal dysfunction.
Source: Cardiovascular Drugs and Therapy - Category: Cardiology Source Type: research